These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9705197)

  • 21. WHO expert committee on specifications for pharmaceutical preparations.
    World Health Organ Tech Rep Ser; 1984; 704():1-54. PubMed ID: 6437087
    [No Abstract]   [Full Text] [Related]  

  • 22. Industry perspective on the medical risk of visible particles in injectable drug products.
    Bukofzer S; Ayres J; Chavez A; Devera M; Miller J; Ross D; Shabushnig J; Vargo S; Watson H; Watson R
    PDA J Pharm Sci Technol; 2015; 69(1):123-39. PubMed ID: 25691720
    [No Abstract]   [Full Text] [Related]  

  • 23. QUAD routes out inferior drugs.
    Can Hosp; 1973 May; 50(5):58-9. PubMed ID: 4779804
    [No Abstract]   [Full Text] [Related]  

  • 24. Combating counterfeit drugs.
    Land T
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731208
    [No Abstract]   [Full Text] [Related]  

  • 25. Spurious and counterfeit drugs: a growing industry in the developing world.
    Gautam CS; Utreja A; Singal GL
    Postgrad Med J; 2009 May; 85(1003):251-6. PubMed ID: 19520877
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drugs in the 3d World. Every profession has its share of responsibility].
    Rosenkvist I
    Sygeplejersken; 1983 Jun; 83(21):24-6. PubMed ID: 6555952
    [No Abstract]   [Full Text] [Related]  

  • 27. Dora Akunyili: battling against counterfeit drugs. Interview by Marilynn Larkin.
    Akunyili D
    Lancet Infect Dis; 2006 Sep; 6(9):554-5. PubMed ID: 16931405
    [No Abstract]   [Full Text] [Related]  

  • 28. Deterring the importation of counterfeit pharmaceutical products.
    Stearn DW
    Food Drug Law J; 2004; 59(4):537-61. PubMed ID: 15875351
    [No Abstract]   [Full Text] [Related]  

  • 29. Using VigiBase to Identify Substandard Medicines: Detection Capacity and Key Prerequisites.
    Juhlin K; Karimi G; Andér M; Camilli S; Dheda M; Har TS; Isahak R; Lee SJ; Vaughan S; Caduff P; Norén GN
    Drug Saf; 2015 Apr; 38(4):373-82. PubMed ID: 25687792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. India: regulator's list of 50 substandard drugs raises questions about oversight and manufacturing.
    Lal N
    BMJ; 2024 Oct; 387():q2149. PubMed ID: 39357900
    [No Abstract]   [Full Text] [Related]  

  • 31. Report on the PQRI impurity characterization and quantification best practices survey.
    Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF
    Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396
    [No Abstract]   [Full Text] [Related]  

  • 32. Safeguarding against substandard/counterfeit drugs: mitigating a macroeconomic pandemic.
    Wertheimer AI; Norris J
    Res Social Adm Pharm; 2009 Mar; 5(1):4-16. PubMed ID: 19285285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimizing the impact of developments in micro-instrumentation on process analytical technology: a consortium approach.
    Koch MV
    Anal Bioanal Chem; 2006 Mar; 384(5):1049-53. PubMed ID: 16049668
    [No Abstract]   [Full Text] [Related]  

  • 34. [Role of an association in promoting pharmaceutical quality assurance: transfer of know-how based on the buddy system].
    Ba A; Courcambeck A; Degui H
    Med Trop (Mars); 2006 Dec; 66(6):538-41. PubMed ID: 17286016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries.
    Maffioli EM; Montás MC; Anyakora C
    J Glob Health; 2024 Jun; 14():03029. PubMed ID: 38843042
    [No Abstract]   [Full Text] [Related]  

  • 36. [To restore trust in drugs].
    Dahan R
    Bull Cancer; 2013 May; 100(5):411-3. PubMed ID: 23862195
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacopoeial quality of drugs supplied by Nigerian pharmacies.
    Taylor RB; Shakoor O; Behrens RH; Everard M; Low AS; Wangboonskul J; Reid RG; Kolawole JA
    Lancet; 2001 Jun; 357(9272):1933-6. PubMed ID: 11425415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Standardization of forensic drug analyses.
    Frank RS; Gunn JW
    J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386
    [No Abstract]   [Full Text] [Related]  

  • 39. Technologies for detecting falsified and substandard drugs in low and middle-income countries.
    Kovacs S; Hawes SE; Maley SN; Mosites E; Wong L; Stergachis A
    PLoS One; 2014; 9(3):e90601. PubMed ID: 24671033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmaceutical drugs-the good and the not so good: together, we can make it better.
    Campbell AW
    Altern Ther Health Med; 2014; 20(1):9-11. PubMed ID: 24445351
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.